跳至主要内容
临床试验/NCT07732283
NCT07732283招募中不适用

4-electrode ECG (DigitalCardio®) vs Standard 10-electrode ECG: Evaluating Ease of Use and Recording Quality

Clinique Bizet4 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2026年9月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
50
试验地点
4
主要终点
Comparison of Procedure Time Between 4-Electrode DigitalCardio® ECG and Standard 12-Lead ECG

研究概览

简要总结

The goal of this clinical trial is to compare the time required to record a complete Electrocardiogram (ECG) trace using the DigitalCardio (CardioSecur®) tablet device versus a standard 12-lead ECG device in eligible patients.

The main questions it aims to answer are:

Is there a difference in diagnostic recording time (in minutes) between the DigitalCardio tablet and a standard ECG machine? How do the two devices compare in terms of trace quality (including QRS duration, QT interval, frontal axis measurements, and missing/erroneous leads)? How satisfied are healthcare professionals with the CardioSecur® device?

Researchers will compare Group A (standard 10-electrode ECG followed by 4-electrode ECG) to Group B (4-electrode ECG followed by standard 10-electrode ECG) in a 1:1 randomized crossover design to evaluate recording efficiency and trace quality.

Participants will:

Complete an initial screening visit with the principal investigator to review eligibility criteria and sign the informed consent form.

Be randomly assigned (1:1 ratio) to either Group A or Group B. Undergo both ECG recording methods sequentially (a standard 10-electrode ECG and a 4-electrode ECG using the DigitalCardio tablet), while researchers measure the total time elapsed from electrode placement to obtaining a complete trace.

详细描述

This study is a randomized, crossover clinical trial designed to compare the efficiency, trace quality, and user satisfaction of a novel 4-electrode tablet-based Electrocardiogram (ECG) system (DigitalCardio / CardioSecur®) against a standard 12-lead (10-electrode) ECG device.

Background and Rationale

An electrocardiogram (ECG) is a fundamental diagnostic tool used to record the electrical activity of the heart. Conventional 12-lead ECGs require placing 10 individual electrodes on a patient's limbs and chest while the patient is lying down. While highly detailed, electrode placement and device setup can be time-consuming in clinical workflows. The DigitalCardio tablet system utilizes a simplified 4-electrode setup designed to streamline data acquisition without compromising diagnostic accuracy.

Study Design and Procedures

After an initial screening process led by the principal investigator, eligible participants receive detailed study information and provide written informed consent. Enrolled participants are then randomly assigned in a 1:1 ratio to one of two sequence groups to control for order effects:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hospitalized Cardiology Patients:
  • Age minimum 18 years
  • Hospitalized for an acute or chronic cardiac condition (e.g., heart failure, acute coronary syndrome, arrhythmia, valvular heart disease, etc.)
  • Ability to give informed consent
  • Hemodynamic stability permitting the performance of an ECG without clinical risk
  • Cardiology Outpatients:
  • Age minimum of 18 years
  • Follow-up for a known cardiac condition or suspected cardiovascular disease
  • No contraindications to performing an ECG
  • Informed consent obtained

排除标准

  • Minor patient (< 18 years of age)
  • Adult subject under legal protection, under temporary guardianship, curatorship, or tutelage
  • Patient refusing to participate in the study
  • Presence of an implantable cardiac device (e.g., pacemaker, defibrillator) that may interfere with ECG measurements
  • Severe skin condition preventing the placement of electrodes
  • Physical or cognitive inability to follow the study protocol
  • Current pregnancy

研究组 & 干预措施

standard 10-electrode ECG

Other

Undergoes standard 10-electrode ECG acquisition first

干预措施: standard 10-electrode ECG acquisition (Device)

standard 10-electrode ECG

Other

Undergoes standard 10-electrode ECG acquisition first

干预措施: 4-electrode DigitalCardio acquisition (Device)

4-electrode DigitalCardio

Active Comparator

Undergoes 4-electrode DigitalCardio

干预措施: standard 10-electrode ECG acquisition (Device)

4-electrode DigitalCardio

Active Comparator

Undergoes 4-electrode DigitalCardio

干预措施: 4-electrode DigitalCardio acquisition (Device)

结局指标

主要结局

Comparison of Procedure Time Between 4-Electrode DigitalCardio® ECG and Standard 12-Lead ECG

时间窗: 1 day

Time elapsed from the initiation of electrode placement to the obtaining of a complete ECG trace for both the 4-electrode DigitalCardio® system and the standard 12-lead ECG device. Unit of Measure: Minutes

次要结局

  • Comparative Quality Assessment of ECG Traces(1 day)
  • Intraclass Correlation Coefficient (ICC) for Quantitative ECG Parameters(1 day)
  • Diagnostic Concordance for Cardiac Pathology(1 day)
  • Healthcare Professional Satisfaction Score(1 days)
  • Incidence of Device-Related Technical Incidents for 4-electrode DigitalCardio® system(1 day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验